| Literature DB >> 25886317 |
Thomas C Williams1, Monica I Espinosa2, Lars K Nielsen3, Claudia E Vickers4.
Abstract
BACKGROUND: Engineering dynamic, environmentally- and temporally-responsive control of gene expression is one of the principle objectives in the field of synthetic biology. Dynamic regulation is desirable because many engineered functions conflict with endogenous processes which have evolved to facilitate growth and survival, and minimising conflict between growth and production phases can improve product titres in microbial cell factories. There are a limited number of mechanisms that enable dynamic regulation in yeast, and fewer still that are appropriate for application in an industrial setting.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25886317 PMCID: PMC4427958 DOI: 10.1186/s12934-015-0223-7
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328
Figure 1Testing promoters for differential expression on sucrose. SUC2, GLC3, MAL12, and GPH1 promoters were used to control GFP expression. Each strain was grown to mid-exponential phase on minimal medium containing 10 g/L glucose or 10 g/L sucrose prior to flow cytometry-based GFP measurement. Mean GFP fluorescence levels in arbitrary units (au) from duplicate fermentations with error bars representing the standard deviation are shown.
Figure 2Tuning the timing of gene expression using different ratios of glucose to sucrose. A strain expressing the destabilized GFP gene driven by the SUC2 promoter was grown in media containing the indicated concentrations of glucose and sucrose. Extracellular glucose, sucrose, and fructose concentrations were measured using HPLC during the initial growth phase alongside GFP expression levels. Population density (OD660nm) and GFP expression levels were measured up to 56 hours of shake-flask cultivation. All data points and error bars represent the mean and standard deviation from triplicate cultivations.
Figure 3Comparison of TEF1 and SUC2 promoter strengths. GFP fluorescence (a) and population density (b) were measured for P -GFP and P -GFP expressing strains in 1% glucose, 1% sucrose containing medium over 48 hours. Mean and standard deviation for triplicate cultivations are shown.
Figure 4Dynamic repression of GFP expression using sucrose mediated RNAi. (a) The expression of an antisense RNA results in the destruction of complementary mRNA via Dicer and Argonaute enzymes. (b) Expression of the full GFP ORF in the antisense direction is triggered during growth on sucrose using the SUC2 promoter, causing constitutively regulated (TEF1 promoter) GFP expression to be repressed via Dicer/Argonaute-mediated RNA interference. GFP expression levels (c), and population density (d) were measured for P -GFP expressing strains both with (‘RNAi’, black triangles) and without (‘control’, green circles) a P -GFP antisense construct. The GFP expression level from the control strain was set to ‘100%’, with GFP expression values from the RNAi strain being normalised to this value. Means ± standard deviations are shown from triplicate cultures. Figure 4b was adapted from [42]. Non-normalised GFP expression values are shown in Additional file 1: Figure S1.
Primers
|
|
|
|---|---|
| MAL12F | TATTATctcgagACCAACCCGAAAATTCTTC |
| MAL12R | TATTATgaattcTTATGTAATTTAGTTACGCTTGAC |
| GPH1F | TATTATGatcgatTAGTTATCCGACTAGCAAG |
| GPH1R | TATTATgaattcTGTTCAAAATTAAATTAAGTTG |
| GLC3F | TATTATctcgagCGGTGATTTACAAGAAGAGG |
| GLC3R | TATTATatcgatTTTATTCTTGACGGTTCTTTATAC |
| SUC2F | TATTATctcgagACATACTAAGACATTTACCG |
| SUC2R | TATTATgaattcCATATACGTTAGTGAAAAGAAAAG |
| XhoI-pTEF1F | TATTATctcgagGCACACACCATAG |
| EcoRI-pTEF1R | TATTATgaattcTTGTAATTAAAACTTAGATTAGATTG |
| GFP1F | TATTATgaattcCTATATTACTTGGGTATTGCCC |
| GFP1R | TATTATcccgggTCTAAAGGTGAAGAATTATTCAC |
| LEU2A2 | ATAGAATTGTGTAGAATTGCAG |
| LEU2D2 | ATGAAATGAACATTGATTTACTATC |
| CYC1tF | TATAATtctagaACAGGCCCCTTTTCCTTTGT |
| CYC1tR | TATTATgagctcACGATGAGAGTGTAAACTGC |
| ApaI-SUC2F | TATTATgggcccACATACTAAGACATTTACCG |
| ClaI-SUC2R | TATTATatcgatCATATACGTTAGTGAAAAGAAAAG |
Restriction enzyme sites are shown in lower case.
Plasmids
|
|
|
|
|---|---|---|
| pRS406 | URA3 integrating vector | [ |
| pSF019 | TEF1 promoter containing vector | [ |
| yEGFPCLN2PEST-pRS406 | Destabilized GFP base plasmid | [ |
| PMAL12- yEGFPCLN2PEST-pRS406 | MAL12 promoter driven GFP expression | This study |
| PGLC3- yEGFPCLN2PEST-pRS406 | GLC3 promoter driven GFP expression | This study |
| PGPH1- yEGFPCLN2PEST-pRS406 | GPH1 promoter driven GFP expression | This study |
| PSUC2- yEGFPCLN2PEST-pRS406 | SUC2 promoter driven GFP expression | This study |
| PTEF1-yEGFPCLN2PEST-406 | Constitutive TEF1 promoter driven GFP expression | This study |
| pRS413 | Yeast centromeric plasmid with HIS3 selection marker | [ |
| CYC1t-pRS413 | CYC1 terminator | This study |
| PSUC2-CYC1t-pRS413 | SUC2 promoter, CYC1 terminator | This study |
| PSUC2-GFPantisense-CYC1t-pRS413 | SUC2 regulated expression of an antisense RNAi construct for GFP | This study |
| pRS404-PTEF -Ago1-CYC1t | TRP1 integrating vector with constitutive Argonaute expression | [ |
| pRS405-PTEF-Dcr1-CYC1t | LEU2 integrating vector with constitutive Dicer expression | [ |
| pUG6 | LoxP-KanMX-LoxP cassette | Euroscarf |
| pUG66 | LoxP-Ble-LoxP cassette | Euroscarf |
strains used in this study
|
|
|
|
|
|---|---|---|---|
| CEN.PK113-5D | MATa; ura3-52; MAL2-8C; SUC2 | Haploid MATa lab strain with uracil auxotrophy | Euroscarf |
| CEN.PK113-7D | MATa; MAL2-8C; SUC2 | Prototrophic haploid MATa lab strain | Euroscarf |
| S01 | CEN.PK2-1c, bar1Δ |
| This study |
| S02 | CEN.PK2-1c, bar1Δ, fus1::KanMX, trp1::pRS404-PTEF-Ago1 |
| This study |
| S03 | CEN.PK2-1c, bar1Δ, fus1::KanMX, trp1::pRS404-PTEF-Ago1, leu2::pRS405-PTEF-Dcr1 | RNAi capable base strain with Argonaute and Dicer integration | This study |
| GFP01 | CEN.PK113-5D, bar1::phleo, fus1::KanMX, ura3-52::PTEF1-GFPCLN2PEST-ADH1t-pRS406 | constitutive destabilized GFP expression | This study |
| GFP02 | CEN.PK113-5D, ura3::PMAL12-GFPCLN2PEST-ADH1t-pRS406 |
| This study |
| GFP03 | CEN.PK113-5D, ura3::PGLC3-GFPCLN2PEST-ADH1t-pRS406 |
| This study |
| GFP04 | CEN.PK113-5D, ura3::PGPH1-GFPCLN2PEST-ADH1t-pRS406 |
| This study |
| GFP05 | CEN.PK113-5D, ura3::PSUC2-GFPCLN2PEST-ADH1t-pRS406 |
| This study |
| GFP06 | CEN.PK2-1c, bar1Δ, fus1::KanMX, ura3:: PTEF1-yEGFPCLN2PEST-406, trp1::pRS404-PTEF-Ago1, leu2::pRS405-PTEF-Dcr1, pRS413 | RNAi capable, constitutive GFP expressing control strain | This study |
| GFP07 | CEN.PK2-1c, bar1Δ, fus1::KanMX, ura3:: PTEF1-yEGFPCLN2PEST-406, trp1::pRS404-PTEF-Ago1, leu2::pRS405-PTEF-Dcr1, PSUC2-GFPantisense-CYC1t-pRS413 |
| This study |